Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyceraldehyde-3-phosphate dehydrogenase pseudogene 77 (GAPDHP77) is a pseudogene related to the functional GAPDH gene, which codes for the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase. As a pseudogene, GAPDHP77 does not encode a functional protein and is generally considered non-coding and non-functional for typical enzymatic or receptor activities. Pseudogenes like GAPDHP77 may arise by gene duplication or retrotransposition events and typically accumulate mutations rendering them inactive. There is currently no evidence associating GAPDHP77 with any therapeutic action, receptor, enzyme function, direct role in disease, or drug interaction[3]. If more specific structured data (e.g., genomic locus, conservation, tissue expression) is required, please clarify, as available references confirm only its identity as a pseudogene with no known functional protein or direct biomedical relevance[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 77 (GAPDHP77).